Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

27 sept. 2025 08h59 HE | Source: Bragar Eagel & Squire

METHODE (MEI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Methode Electronics Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Methode allegedly misled investors on its EV transition, hiding Monterrey facility issues, staffing losses, and failures derailing revenue and guidance.
27 sept. 2025 08h55 HE | Source: Bragar Eagel & Squire

SERITAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Seritage Growth Properties on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Seritage allegedly overstated asset values and hid control weaknesses; disclosures in 2023–24 led to stock drops of 10% and 27% on heavy trading.
27 sept. 2025 08h31 HE | Source: Bragar Eagel & Squire

LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Lifecore allegedly hid deficient controls, misstated financials, failed remediation, and risked SEC filing delays, overstating its position.
27 sept. 2025 08h30 HE | Source: Bragar Eagel & Squire

ZYNEX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Zynex, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Zynex allegedly concealed an oversupply scheme; Tricare suspended payments, and shares plunged 51% on March 12, 2025, after revenue shortfall news.
27 sept. 2025 08h24 HE | Source: Bragar Eagel & Squire

MARINUS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Marinus Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Marinus allegedly understated RAISE trial risks and failed to disclose RAISE II impacts, making its business statements false and misleading.
27 sept. 2025 08h24 HE | Source: Bragar Eagel & Squire

FLUENCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fluence Energy, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Fluence allegedly misled investors on ties with Siemens & AES, hiding disputes, divestment risks, and inflated growth, causing investor losses.
27 sept. 2025 08h19 HE | Source: Bragar Eagel & Squire

ABR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Arbor Realty Trust, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

ABR allegedly misled investors on loan book and income; reports and a federal probe revealed distressed assets, causing sharp stock declines.
27 sept. 2025 08h19 HE | Source: Bragar Eagel & Squire

BIGBEAR ALERT: Bragar Eagel & Squire, P.C. is Investigating BigBear.ai Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

BigBear.ai allegedly misaccounted 2026 Convertible Notes, misstating financials that may require restatement, exposing investors to losses.
27 sept. 2025 08h11 HE | Source: Bragar Eagel & Squire

MAISON SOLUTIONS (MSS) ALERT: Bragar Eagel & Squire, P.C. is Investigating Maison Solutions on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Maison allegedly misled investors in IPO filings by hiding related-party ties, poor auditor/underwriter history, and CEO Xu’s past legal issues.
27 sept. 2025 08h05 HE | Source: Bragar Eagel & Squire

HUMANA (HUM) ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Humana allegedly downplayed rising medical costs from pent-up demand, with disclosures in 2023–24 showing higher utilization that hit earnings and stock.

Page suivante